Impact Factor
3.79
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.85
3,751 total citations
h5-index
59
h5 depth signal
Cited share
69.0%
930 of 1,348
Total citations
3,751
Citation footprint
Metric signal
3.00
External metric anchor
Self-citation
4.6%
173 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,960
United Kingdom
1,396
France
715
Italy
713
China
644
Citing Fields of Research
Hematology
4,658
Lymphomas
2,176
Immunology
793
Clinical Laboratory Science
393
Oncology
381
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
28,587
Articles tracked across the journal lifetime
Indexed publication set
1,348
930 cited publications
Last 12 months
694
57.8 publications/month
Open access share
48.0%
333 OA publications in the last year
Leading citing country
United States
1,960 citing publications
Leading citing field
Hematology
4,658 citing publications
Latest tracked publication
21 October 2026
10 recent records available
Coverage & Indexing History
v11n5,Sept. 1965-
v11n5,Sept. 1965-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Lymphomas
Broad Categories
Hematology
Lymphomas
MeSH Descriptors
Hematology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1111/bjh.70880
Open DOI
Patient‐specific genomic measurable residual disease markers for monitoring acute myeloid leukaemia and myeloid malignancy
Summary: Measurable residual disease (MRD) has improved acute lymphoblastic leukaemia (ALL) outcomes. Applying acute myeloid leukaemia (AML) MRD has been limited due to complexity identifying leukaemia‐specific targets. Current AML MRD r...
03
DOI 10.1111/bjh.70908
Open DOI
In a Nutshell: Immune alterations in classic Hodgkin lymphoma
04
05
DOI 10.1111/bjh.70892
Open DOI
A real‐world multi‐institution experience of standard versus alternative dosing regimens of inotuzumab ozogamicin for relapsed/refractory paediatric B‐cell acute lymphoblastic leukaemia
Summary: Inotuzumab ozogamicin (InO) is approved by the U.S. Food and Drug Administration (FDA) for relapsed/refractory (R/R) B‐cell acute lymphoblastic leukaemia (B‐ALL), with a standard schedule of 1.8 mg/m 2 fractionated into three do...
06
DOI 10.1111/bjh.70890
Open DOI
Allogeneic transplantation versus non‐transplant treatment for classical paroxysmal nocturnal haemoglobinuria without complement inhibitors
Summary: To describe outcomes after haematopoietic stem cell transplantation (HSCT) and non‐transplant treatment in patients with classical paroxysmal nocturnal haemoglobinuria (cPNH) without access to complement inhibitors, we analysed ...
07
DOI 10.1111/bjh.70894
Open DOI
Association of enlarged perivascular space burden with silent cerebral infarcts in children with sickle cell disease
Summary: Children with sickle cell disease (SCD) have enlarged perivascular spaces (ePVS) in their basal ganglia (BG) and centrum semiovale (CSO) visible on magnetic resonance imaging (MRI). ePVS are dilated fluid‐filled spaces around pe...
08
DOI 10.1111/bjh.70893
Open DOI
Identification of rare blood group donors from biobank data
Summary: Safe blood transfusion relies on avoiding clinically significant incompatibilities between recipient antibodies and donor red blood cell antigens, a requirement that becomes particularly challenging for patients with rare blood ...
09
DOI 10.1111/bjh.70909
Open DOI
Subtype‐ and functional class‐dependent prognostic impact of CSF3R mutations in acute myeloid leukaemia: A cohort study of 2500 patients
Summary: Colony‐stimulating factor 3 receptor ( CSF3R ) mutations occur in acute myeloid leukaemia (AML), but their prognostic significance remains unclear. We analysed 2500 patients with newly diagnosed de novo non‐acute promyelocytic l...
10
Bibliographical & Catalog Notes
Has occasional supplement.
Also issued online.
Microfilm. v. 16-19 (1969-1970) 4 microfilm reels : negative ; 35 mm.